Paramagnetic Rim Lesions in Pediatric Multiple Sclerosis and Their Association With Brain Tissue Atrophy

Riccardo Nistri1,2, Ermelinda De Meo1, Nee Na Kim1,2

  • 1Queen Square MS Center, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, United Kingdom.

Abstract

Insights

Paramagnetic rim lesions (PRLs) are common in pediatric multiple sclerosis (MS), indicating active inflammation. Higher PRL counts correlate with increased lesion burden and gray matter atrophy in children with MS.

Area of Science:

  • Neuroimaging
  • Pediatric Neurology
  • Inflammatory Diseases

Background:

  • Paramagnetic rim lesions (PRLs) on susceptibility-based imaging (SbI) signify chronic active inflammation in multiple sclerosis (MS).
  • In adult MS, PRLs are linked to a more aggressive disease course.
  • The prevalence and significance of PRLs in pediatric MS remain less understood.

Purpose of the Study:

  • To determine the prevalence of PRLs in children diagnosed with MS.
  • To investigate the association between baseline PRL count and clinical disability.
  • To examine the relationship between baseline PRL count and brain tissue volume loss, both cross-sectionally and over short-term follow-up.

Main Methods:

  • Retrospective analysis of pediatric MS patients from UK neuroimmunology centers.
  • MRI data including SbI were analyzed to identify and classify PRLs.
  • Brain volumes were segmented, and associations with PRL burden, clinical variables, and longitudinal changes were assessed using regression models.

Main Results:

  • 74.1% of pediatric MS patients had at least one PRL, with a median of 2.
  • Higher PRL counts were associated with greater T2-hyperintense lesion burden.
  • Increased PRL count correlated with lower gray matter volume z-scores and predicted greater deep gray matter volume loss over 17 months.

Conclusions:

  • PRLs are prevalent in pediatric MS and indicate significant brain tissue damage, including gray matter atrophy.
  • PRLs may serve as valuable imaging biomarkers for disease severity in pediatric MS.
  • Further long-term studies are needed to confirm the predictive ability of PRLs for future disability in pediatric MS.